JAMES DIAMANTOPOULOS: Open Payments
NPI 1871225904 · BRIGHTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,742 in 57 payments from 12 companies in 2025. Trend: 2023 $1,166 · 2024 $2,871 · 2025 $1,742
Food & beverage: $1,677Education: $65
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $425 |
| ABBVIE INC. | 18 | $205 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $196 |
| LEO Pharma Inc. | 1 | $144 |
| E.R. Squibb & Sons, L.L.C. | 6 | $141 |
| Novartis Pharmaceuticals Corporation | 1 | $139 |
| Janssen Biotech, Inc. | 9 | $135 |
| UCB, Inc. | 5 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $107 |
| Lilly USA, LLC | 4 | $104 |
Products named: Otezla, ILUMYA, ADBRY, Sotyktu, TREMFYA, SKYRIZI, Bimzelx, SPEVIGO.
Industry payments across MA — which companies pay providers there.
